Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Finances

4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD

(RTTNews) – 4D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial evaluating

Finances

4D Molecular Therapeutics Reports Positive Interim Data From Phase 2b Trial For Wet AMD

(RTTNews) – 4D Molecular Therapeutics (FDMT) announced positive initial interim 52-week data from the Phase 2b Population Extension cohort of the PRISM clinical trial evaluating